4BCZ - JenaLib

Asymmetric Unit (Jmol Viewer)

Biological Unit 1 (Jmol Viewer)

Biological Unit 2 (Jmol Viewer)

Title :   MONOMERIC HUMAN CU,ZN SUPEROXIDE DISMUTASE, LOOPS IV AND VII DELETED, APO FORM.

Authors :   K. Saraboji, W. Awad, J. Danielsson, L. Lang, M. Kurnik, S. L. Marklund, M. Oliveberg, D. T. Logan

Date :   03 Oct 12 (Deposition) - 27 Feb 13 (Release) - 20 Mar 13 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   1.93

Chains :   Asym. Unit : A,B
Biol. Unit 1: A  (1x)
Biol. Unit 2: B  (1x)

Keywords :   Oxidoreductase, Cu/Zn Sod1, Monomeric Mutant, Disease Mutation, Metal Binding, Neurodegeneration, Als (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   J. Danielsson, W. Awad, K. Saraboji, M. Kurnik, L. Lang, L. Leinartaite, S. L. Marklund, D. T. Logan, M. Oliveberg
Global Structural Motions From The Strain Of A Single Hydrogen Bond.
Proc. Natl. Acad. Sci. Usa V. 110 3829 2013
PubMed-ID: 23431167 | Reference-DOI: 10.1073/PNAS.1217306110

Molecule 1 - SUPEROXIDE DISMUTASE [CU-ZN]
	Chains	:	A, B
	EC Number	:	1.15.1.1
	Engineered	:	YES
	Expression System	:	ESCHERICHIA COLI
	Expression System Strain	:	BL21(DE3)
	Expression System Taxid	:	469008
	Fragment	:	RESIDUES 2049,83-124,141-154
	Mutation	:	YES
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	SUPEROXIDE DISMUTASE 1, HSOD1

		1	2
Asymmetric Unit	:	A	B
Biological Unit 1 (1x)	:	A
Biological Unit 2 (1x)	:		B

Summary Information (see also Sequences/Alignments below)

(no "Ligand,Modified Residues,Ions" information available for 4BCZ)

(no "Site" information available for 4BCZ)

(no "SS Bond" information available for 4BCZ)

(no "Cis Peptide Bond" information available for 4BCZ)

Asymmetric Unit (66, 132)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_013518	A	5	S	SODC_HUMAN	Disease (ALS1)	---	A/B	A	4	S
02	UniProt	VAR_007130	A	5	T	SODC_HUMAN	Disease (ALS1)	121912444	A/B	A	4	T
03	UniProt	VAR_007131	A	5	V	SODC_HUMAN	Disease (ALS1)	121912442	A/B	A	4	V
04	UniProt	VAR_008717	C	7	F	SODC_HUMAN	Disease (ALS1)	121912448	A/B	A	6	F
05	UniProt	VAR_007132	V	8	E	SODC_HUMAN	Disease (ALS1)	---	A/B	V	7	E
06	UniProt	VAR_013519	L	9	Q	SODC_HUMAN	Disease (ALS1)	---	A/B	L	8	Q
07	UniProt	VAR_013520	L	9	V	SODC_HUMAN	Disease (ALS1)	---	A/B	L	8	V
08	UniProt	VAR_013521	G	13	R	SODC_HUMAN	Disease (ALS1)	121912456	A/B	G	12	R
09	UniProt	VAR_013522	V	15	G	SODC_HUMAN	Disease (ALS1)	---	A/B	V	14	G
10	UniProt	VAR_007133	V	15	M	SODC_HUMAN	Disease (ALS1)	---	A/B	V	14	M
11	UniProt	VAR_007134	G	17	S	SODC_HUMAN	Disease (ALS1)	121912453	A/B	G	16	S
12	UniProt	VAR_045876	F	21	C	SODC_HUMAN	Disease (ALS1)	---	A/B	F	20	C
13	UniProt	VAR_013523	E	22	G	SODC_HUMAN	Disease (ALS1)	---	A/B	E	21	G
14	UniProt	VAR_007135	E	22	K	SODC_HUMAN	Disease (ALS1)	121912450	A/B	E	21	K
15	UniProt	VAR_045877	Q	23	L	SODC_HUMAN	Disease (ALS1)	---	A/B	Q	22	L
16	UniProt	VAR_007136	G	38	R	SODC_HUMAN	Disease (ALS1)	121912431	A/B	G	37	R
17	UniProt	VAR_013524	L	39	R	SODC_HUMAN	Disease (ALS1)	---	A/B	L	38	R
18	UniProt	VAR_007137	L	39	V	SODC_HUMAN	Disease (ALS1)	121912432	A/B	L	38	V
19	UniProt	VAR_007139	G	42	D	SODC_HUMAN	Disease (ALS1)	121912434	A/B	G	41	D
20	UniProt	VAR_007138	G	42	S	SODC_HUMAN	Disease (ALS1)	121912433	A/B	G	41	S
21	UniProt	VAR_007140	H	44	R	SODC_HUMAN	Disease (ALS1)	121912435	A/B	H	43	R
22	UniProt	VAR_013525	F	46	C	SODC_HUMAN	Disease (ALS1)	121912457	A/B	F	45	C
23	UniProt	VAR_007141	H	47	R	SODC_HUMAN	Disease (ALS1)	121912443	A/B	H	46	R
24	UniProt	VAR_007142	H	49	Q	SODC_HUMAN	Disease (ALS1)	---	A/B	H	48	Q
25	UniProt	VAR_045878	H	49	R	SODC_HUMAN	Disease (ALS1)	---	A/B	H	48	R
26	UniProt	VAR_013526	E	50	K	SODC_HUMAN	Disease (ALS1)	---	A/B	G	49	K
27	UniProt	VAR_013530	L	85	F	SODC_HUMAN	Disease (ALS1)	---	A/B	L	54	F
28	UniProt	VAR_007143	L	85	V	SODC_HUMAN	Disease (ALS1)	121912452	A/B	L	54	V
29	UniProt	VAR_007144	G	86	R	SODC_HUMAN	Disease (ALS1)	121912436	A/B	G	55	R
30	UniProt	VAR_013531	N	87	S	SODC_HUMAN	Disease (ALS1)	11556620	A/B	N	56	S
31	UniProt	VAR_045880	V	88	A	SODC_HUMAN	Disease (ALS1)	---	A/B	V	57	A
32	UniProt	VAR_045881	A	90	T	SODC_HUMAN	Disease (ALS1)	---	A/B	A	59	T
33	UniProt	VAR_013532	A	90	V	SODC_HUMAN	Disease (ALS1)	---	A/B	A	59	V
34	UniProt	VAR_007145	D	91	A	SODC_HUMAN	Disease (ALS1)	80265967	A/B	D	60	A
35	UniProt	VAR_013533	D	91	V	SODC_HUMAN	Disease (ALS1)	---	A/B	D	60	V
36	UniProt	VAR_007146	G	94	A	SODC_HUMAN	Disease (ALS1)	121912438	A/B	G	63	A
37	UniProt	VAR_007147	G	94	C	SODC_HUMAN	Disease (ALS1)	121912437	A/B	G	63	C
38	UniProt	VAR_007148	G	94	D	SODC_HUMAN	Disease (ALS1)	---	A/B	G	63	D
39	UniProt	VAR_007149	G	94	R	SODC_HUMAN	Disease (ALS1)	121912437	A/B	G	63	R
40	UniProt	VAR_008719	G	94	V	SODC_HUMAN	Disease (ALS1)	---	A/B	G	63	V
41	UniProt	VAR_065194	A	96	G	SODC_HUMAN	Disease (ALS1)	---	A/B	A	65	G
42	UniProt	VAR_045882	V	98	M	SODC_HUMAN	Disease (ALS1)	---	A/B	V	67	M
43	UniProt	VAR_007150	E	101	G	SODC_HUMAN	Disease (ALS1)	121912439	A/B	E	70	G
44	UniProt	VAR_013534	E	101	K	SODC_HUMAN	Disease (ALS1)	---	A/B	E	70	K
45	UniProt	VAR_007151	D	102	G	SODC_HUMAN	Disease (ALS1)	---	A/B	D	71	G
46	UniProt	VAR_007152	D	102	N	SODC_HUMAN	Disease (ALS1)	---	A/B	D	71	N
47	UniProt	VAR_008720	I	105	F	SODC_HUMAN	Disease (ALS1)	121912445	A/B	I	74	F
48	UniProt	VAR_013535	S	106	L	SODC_HUMAN	Disease (ALS1)	---	A/B	S	75	L
49	UniProt	VAR_007153	L	107	V	SODC_HUMAN	Disease (ALS1)	121912440	A/B	L	76	V
50	UniProt	VAR_013536	G	109	V	SODC_HUMAN	Disease (ALS1)	---	A/B	G	78	V
51	UniProt	VAR_077327	C	112	Y	SODC_HUMAN	Disease (ALS1)	---	A/B	S	81	Y
52	UniProt	VAR_013537	I	113	M	SODC_HUMAN	Disease (ALS1)	---	A/B	I	82	M
53	UniProt	VAR_007154	I	113	T	SODC_HUMAN	Disease (ALS1)	74315452	A/B	I	82	T
54	UniProt	VAR_007155	I	114	T	SODC_HUMAN	Disease (ALS1)	121912441	A/B	I	83	T
55	UniProt	VAR_013538	G	115	A	SODC_HUMAN	Disease (ALS1)	---	A/B	G	84	A
56	UniProt	VAR_007156	R	116	G	SODC_HUMAN	Disease (ALS1)	---	A/B	R	85	G
57	UniProt	VAR_045883	V	119	L	SODC_HUMAN	Disease (ALS1)	---	A/B	V	88	L
58	UniProt	VAR_007160	L	145	F	SODC_HUMAN	Disease (ALS1)	---	A/B	L	101	F
59	UniProt	VAR_008724	L	145	S	SODC_HUMAN	Disease (ALS1)	121912446	A/B	L	101	S
60	UniProt	VAR_008725	A	146	T	SODC_HUMAN	Disease (ALS1)	121912447	A/B	A	102	T
61	UniProt	VAR_013540	C	147	R	SODC_HUMAN	Disease (ALS1)	---	A/B	S	103	R
62	UniProt	VAR_045885	G	148	R	SODC_HUMAN	Disease (ALS1)	---	A/B	G	104	R
63	UniProt	VAR_007161	V	149	G	SODC_HUMAN	Disease (ALS1)	---	A/B	V	105	G
64	UniProt	VAR_007162	V	149	I	SODC_HUMAN	Disease (ALS1)	567511139	A/B	V	105	I
65	UniProt	VAR_007163	I	150	T	SODC_HUMAN	Disease (ALS1)	---	A/B	I	106	T
66	UniProt	VAR_007164	I	152	T	SODC_HUMAN	Disease (ALS1)	121912449	A/B	I	108	T

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (66, 66)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_013518	A	5	S	SODC_HUMAN	Disease (ALS1)	---	A	A	4	S
02	UniProt	VAR_007130	A	5	T	SODC_HUMAN	Disease (ALS1)	121912444	A	A	4	T
03	UniProt	VAR_007131	A	5	V	SODC_HUMAN	Disease (ALS1)	121912442	A	A	4	V
04	UniProt	VAR_008717	C	7	F	SODC_HUMAN	Disease (ALS1)	121912448	A	A	6	F
05	UniProt	VAR_007132	V	8	E	SODC_HUMAN	Disease (ALS1)	---	A	V	7	E
06	UniProt	VAR_013519	L	9	Q	SODC_HUMAN	Disease (ALS1)	---	A	L	8	Q
07	UniProt	VAR_013520	L	9	V	SODC_HUMAN	Disease (ALS1)	---	A	L	8	V
08	UniProt	VAR_013521	G	13	R	SODC_HUMAN	Disease (ALS1)	121912456	A	G	12	R
09	UniProt	VAR_013522	V	15	G	SODC_HUMAN	Disease (ALS1)	---	A	V	14	G
10	UniProt	VAR_007133	V	15	M	SODC_HUMAN	Disease (ALS1)	---	A	V	14	M
11	UniProt	VAR_007134	G	17	S	SODC_HUMAN	Disease (ALS1)	121912453	A	G	16	S
12	UniProt	VAR_045876	F	21	C	SODC_HUMAN	Disease (ALS1)	---	A	F	20	C
13	UniProt	VAR_013523	E	22	G	SODC_HUMAN	Disease (ALS1)	---	A	E	21	G
14	UniProt	VAR_007135	E	22	K	SODC_HUMAN	Disease (ALS1)	121912450	A	E	21	K
15	UniProt	VAR_045877	Q	23	L	SODC_HUMAN	Disease (ALS1)	---	A	Q	22	L
16	UniProt	VAR_007136	G	38	R	SODC_HUMAN	Disease (ALS1)	121912431	A	G	37	R
17	UniProt	VAR_013524	L	39	R	SODC_HUMAN	Disease (ALS1)	---	A	L	38	R
18	UniProt	VAR_007137	L	39	V	SODC_HUMAN	Disease (ALS1)	121912432	A	L	38	V
19	UniProt	VAR_007139	G	42	D	SODC_HUMAN	Disease (ALS1)	121912434	A	G	41	D
20	UniProt	VAR_007138	G	42	S	SODC_HUMAN	Disease (ALS1)	121912433	A	G	41	S
21	UniProt	VAR_007140	H	44	R	SODC_HUMAN	Disease (ALS1)	121912435	A	H	43	R
22	UniProt	VAR_013525	F	46	C	SODC_HUMAN	Disease (ALS1)	121912457	A	F	45	C
23	UniProt	VAR_007141	H	47	R	SODC_HUMAN	Disease (ALS1)	121912443	A	H	46	R
24	UniProt	VAR_007142	H	49	Q	SODC_HUMAN	Disease (ALS1)	---	A	H	48	Q
25	UniProt	VAR_045878	H	49	R	SODC_HUMAN	Disease (ALS1)	---	A	H	48	R
26	UniProt	VAR_013526	E	50	K	SODC_HUMAN	Disease (ALS1)	---	A	G	49	K
27	UniProt	VAR_013530	L	85	F	SODC_HUMAN	Disease (ALS1)	---	A	L	54	F
28	UniProt	VAR_007143	L	85	V	SODC_HUMAN	Disease (ALS1)	121912452	A	L	54	V
29	UniProt	VAR_007144	G	86	R	SODC_HUMAN	Disease (ALS1)	121912436	A	G	55	R
30	UniProt	VAR_013531	N	87	S	SODC_HUMAN	Disease (ALS1)	11556620	A	N	56	S
31	UniProt	VAR_045880	V	88	A	SODC_HUMAN	Disease (ALS1)	---	A	V	57	A
32	UniProt	VAR_045881	A	90	T	SODC_HUMAN	Disease (ALS1)	---	A	A	59	T
33	UniProt	VAR_013532	A	90	V	SODC_HUMAN	Disease (ALS1)	---	A	A	59	V
34	UniProt	VAR_007145	D	91	A	SODC_HUMAN	Disease (ALS1)	80265967	A	D	60	A
35	UniProt	VAR_013533	D	91	V	SODC_HUMAN	Disease (ALS1)	---	A	D	60	V
36	UniProt	VAR_007146	G	94	A	SODC_HUMAN	Disease (ALS1)	121912438	A	G	63	A
37	UniProt	VAR_007147	G	94	C	SODC_HUMAN	Disease (ALS1)	121912437	A	G	63	C
38	UniProt	VAR_007148	G	94	D	SODC_HUMAN	Disease (ALS1)	---	A	G	63	D
39	UniProt	VAR_007149	G	94	R	SODC_HUMAN	Disease (ALS1)	121912437	A	G	63	R
40	UniProt	VAR_008719	G	94	V	SODC_HUMAN	Disease (ALS1)	---	A	G	63	V
41	UniProt	VAR_065194	A	96	G	SODC_HUMAN	Disease (ALS1)	---	A	A	65	G
42	UniProt	VAR_045882	V	98	M	SODC_HUMAN	Disease (ALS1)	---	A	V	67	M
43	UniProt	VAR_007150	E	101	G	SODC_HUMAN	Disease (ALS1)	121912439	A	E	70	G
44	UniProt	VAR_013534	E	101	K	SODC_HUMAN	Disease (ALS1)	---	A	E	70	K
45	UniProt	VAR_007151	D	102	G	SODC_HUMAN	Disease (ALS1)	---	A	D	71	G
46	UniProt	VAR_007152	D	102	N	SODC_HUMAN	Disease (ALS1)	---	A	D	71	N
47	UniProt	VAR_008720	I	105	F	SODC_HUMAN	Disease (ALS1)	121912445	A	I	74	F
48	UniProt	VAR_013535	S	106	L	SODC_HUMAN	Disease (ALS1)	---	A	S	75	L
49	UniProt	VAR_007153	L	107	V	SODC_HUMAN	Disease (ALS1)	121912440	A	L	76	V
50	UniProt	VAR_013536	G	109	V	SODC_HUMAN	Disease (ALS1)	---	A	G	78	V
51	UniProt	VAR_077327	C	112	Y	SODC_HUMAN	Disease (ALS1)	---	A	S	81	Y
52	UniProt	VAR_013537	I	113	M	SODC_HUMAN	Disease (ALS1)	---	A	I	82	M
53	UniProt	VAR_007154	I	113	T	SODC_HUMAN	Disease (ALS1)	74315452	A	I	82	T
54	UniProt	VAR_007155	I	114	T	SODC_HUMAN	Disease (ALS1)	121912441	A	I	83	T
55	UniProt	VAR_013538	G	115	A	SODC_HUMAN	Disease (ALS1)	---	A	G	84	A
56	UniProt	VAR_007156	R	116	G	SODC_HUMAN	Disease (ALS1)	---	A	R	85	G
57	UniProt	VAR_045883	V	119	L	SODC_HUMAN	Disease (ALS1)	---	A	V	88	L
58	UniProt	VAR_007160	L	145	F	SODC_HUMAN	Disease (ALS1)	---	A	L	101	F
59	UniProt	VAR_008724	L	145	S	SODC_HUMAN	Disease (ALS1)	121912446	A	L	101	S
60	UniProt	VAR_008725	A	146	T	SODC_HUMAN	Disease (ALS1)	121912447	A	A	102	T
61	UniProt	VAR_013540	C	147	R	SODC_HUMAN	Disease (ALS1)	---	A	S	103	R
62	UniProt	VAR_045885	G	148	R	SODC_HUMAN	Disease (ALS1)	---	A	G	104	R
63	UniProt	VAR_007161	V	149	G	SODC_HUMAN	Disease (ALS1)	---	A	V	105	G
64	UniProt	VAR_007162	V	149	I	SODC_HUMAN	Disease (ALS1)	567511139	A	V	105	I
65	UniProt	VAR_007163	I	150	T	SODC_HUMAN	Disease (ALS1)	---	A	I	106	T
66	UniProt	VAR_007164	I	152	T	SODC_HUMAN	Disease (ALS1)	121912449	A	I	108	T

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (66, 66)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_013518	A	5	S	SODC_HUMAN	Disease (ALS1)	---	B	A	4	S
02	UniProt	VAR_007130	A	5	T	SODC_HUMAN	Disease (ALS1)	121912444	B	A	4	T
03	UniProt	VAR_007131	A	5	V	SODC_HUMAN	Disease (ALS1)	121912442	B	A	4	V
04	UniProt	VAR_008717	C	7	F	SODC_HUMAN	Disease (ALS1)	121912448	B	A	6	F
05	UniProt	VAR_007132	V	8	E	SODC_HUMAN	Disease (ALS1)	---	B	V	7	E
06	UniProt	VAR_013519	L	9	Q	SODC_HUMAN	Disease (ALS1)	---	B	L	8	Q
07	UniProt	VAR_013520	L	9	V	SODC_HUMAN	Disease (ALS1)	---	B	L	8	V
08	UniProt	VAR_013521	G	13	R	SODC_HUMAN	Disease (ALS1)	121912456	B	G	12	R
09	UniProt	VAR_013522	V	15	G	SODC_HUMAN	Disease (ALS1)	---	B	V	14	G
10	UniProt	VAR_007133	V	15	M	SODC_HUMAN	Disease (ALS1)	---	B	V	14	M
11	UniProt	VAR_007134	G	17	S	SODC_HUMAN	Disease (ALS1)	121912453	B	G	16	S
12	UniProt	VAR_045876	F	21	C	SODC_HUMAN	Disease (ALS1)	---	B	F	20	C
13	UniProt	VAR_013523	E	22	G	SODC_HUMAN	Disease (ALS1)	---	B	E	21	G
14	UniProt	VAR_007135	E	22	K	SODC_HUMAN	Disease (ALS1)	121912450	B	E	21	K
15	UniProt	VAR_045877	Q	23	L	SODC_HUMAN	Disease (ALS1)	---	B	Q	22	L
16	UniProt	VAR_007136	G	38	R	SODC_HUMAN	Disease (ALS1)	121912431	B	G	37	R
17	UniProt	VAR_013524	L	39	R	SODC_HUMAN	Disease (ALS1)	---	B	L	38	R
18	UniProt	VAR_007137	L	39	V	SODC_HUMAN	Disease (ALS1)	121912432	B	L	38	V
19	UniProt	VAR_007139	G	42	D	SODC_HUMAN	Disease (ALS1)	121912434	B	G	41	D
20	UniProt	VAR_007138	G	42	S	SODC_HUMAN	Disease (ALS1)	121912433	B	G	41	S
21	UniProt	VAR_007140	H	44	R	SODC_HUMAN	Disease (ALS1)	121912435	B	H	43	R
22	UniProt	VAR_013525	F	46	C	SODC_HUMAN	Disease (ALS1)	121912457	B	F	45	C
23	UniProt	VAR_007141	H	47	R	SODC_HUMAN	Disease (ALS1)	121912443	B	H	46	R
24	UniProt	VAR_007142	H	49	Q	SODC_HUMAN	Disease (ALS1)	---	B	H	48	Q
25	UniProt	VAR_045878	H	49	R	SODC_HUMAN	Disease (ALS1)	---	B	H	48	R
26	UniProt	VAR_013526	E	50	K	SODC_HUMAN	Disease (ALS1)	---	B	G	49	K
27	UniProt	VAR_013530	L	85	F	SODC_HUMAN	Disease (ALS1)	---	B	L	54	F
28	UniProt	VAR_007143	L	85	V	SODC_HUMAN	Disease (ALS1)	121912452	B	L	54	V
29	UniProt	VAR_007144	G	86	R	SODC_HUMAN	Disease (ALS1)	121912436	B	G	55	R
30	UniProt	VAR_013531	N	87	S	SODC_HUMAN	Disease (ALS1)	11556620	B	N	56	S
31	UniProt	VAR_045880	V	88	A	SODC_HUMAN	Disease (ALS1)	---	B	V	57	A
32	UniProt	VAR_045881	A	90	T	SODC_HUMAN	Disease (ALS1)	---	B	A	59	T
33	UniProt	VAR_013532	A	90	V	SODC_HUMAN	Disease (ALS1)	---	B	A	59	V
34	UniProt	VAR_007145	D	91	A	SODC_HUMAN	Disease (ALS1)	80265967	B	D	60	A
35	UniProt	VAR_013533	D	91	V	SODC_HUMAN	Disease (ALS1)	---	B	D	60	V
36	UniProt	VAR_007146	G	94	A	SODC_HUMAN	Disease (ALS1)	121912438	B	G	63	A
37	UniProt	VAR_007147	G	94	C	SODC_HUMAN	Disease (ALS1)	121912437	B	G	63	C
38	UniProt	VAR_007148	G	94	D	SODC_HUMAN	Disease (ALS1)	---	B	G	63	D
39	UniProt	VAR_007149	G	94	R	SODC_HUMAN	Disease (ALS1)	121912437	B	G	63	R
40	UniProt	VAR_008719	G	94	V	SODC_HUMAN	Disease (ALS1)	---	B	G	63	V
41	UniProt	VAR_065194	A	96	G	SODC_HUMAN	Disease (ALS1)	---	B	A	65	G
42	UniProt	VAR_045882	V	98	M	SODC_HUMAN	Disease (ALS1)	---	B	V	67	M
43	UniProt	VAR_007150	E	101	G	SODC_HUMAN	Disease (ALS1)	121912439	B	E	70	G
44	UniProt	VAR_013534	E	101	K	SODC_HUMAN	Disease (ALS1)	---	B	E	70	K
45	UniProt	VAR_007151	D	102	G	SODC_HUMAN	Disease (ALS1)	---	B	D	71	G
46	UniProt	VAR_007152	D	102	N	SODC_HUMAN	Disease (ALS1)	---	B	D	71	N
47	UniProt	VAR_008720	I	105	F	SODC_HUMAN	Disease (ALS1)	121912445	B	I	74	F
48	UniProt	VAR_013535	S	106	L	SODC_HUMAN	Disease (ALS1)	---	B	S	75	L
49	UniProt	VAR_007153	L	107	V	SODC_HUMAN	Disease (ALS1)	121912440	B	L	76	V
50	UniProt	VAR_013536	G	109	V	SODC_HUMAN	Disease (ALS1)	---	B	G	78	V
51	UniProt	VAR_077327	C	112	Y	SODC_HUMAN	Disease (ALS1)	---	B	S	81	Y
52	UniProt	VAR_013537	I	113	M	SODC_HUMAN	Disease (ALS1)	---	B	I	82	M
53	UniProt	VAR_007154	I	113	T	SODC_HUMAN	Disease (ALS1)	74315452	B	I	82	T
54	UniProt	VAR_007155	I	114	T	SODC_HUMAN	Disease (ALS1)	121912441	B	I	83	T
55	UniProt	VAR_013538	G	115	A	SODC_HUMAN	Disease (ALS1)	---	B	G	84	A
56	UniProt	VAR_007156	R	116	G	SODC_HUMAN	Disease (ALS1)	---	B	R	85	G
57	UniProt	VAR_045883	V	119	L	SODC_HUMAN	Disease (ALS1)	---	B	V	88	L
58	UniProt	VAR_007160	L	145	F	SODC_HUMAN	Disease (ALS1)	---	B	L	101	F
59	UniProt	VAR_008724	L	145	S	SODC_HUMAN	Disease (ALS1)	121912446	B	L	101	S
60	UniProt	VAR_008725	A	146	T	SODC_HUMAN	Disease (ALS1)	121912447	B	A	102	T
61	UniProt	VAR_013540	C	147	R	SODC_HUMAN	Disease (ALS1)	---	B	S	103	R
62	UniProt	VAR_045885	G	148	R	SODC_HUMAN	Disease (ALS1)	---	B	G	104	R
63	UniProt	VAR_007161	V	149	G	SODC_HUMAN	Disease (ALS1)	---	B	V	105	G
64	UniProt	VAR_007162	V	149	I	SODC_HUMAN	Disease (ALS1)	567511139	B	V	105	I
65	UniProt	VAR_007163	I	150	T	SODC_HUMAN	Disease (ALS1)	---	B	I	106	T
66	UniProt	VAR_007164	I	152	T	SODC_HUMAN	Disease (ALS1)	121912449	B	I	108	T

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric Unit (2, 4)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	SOD_CU_ZN_1	PS00087	Copper/Zinc superoxide dismutase signature 1.	SODC_HUMAN	45-55	2	A:44-51 B:44-51
2	SOD_CU_ZN_2	PS00332	Copper/Zinc superoxide dismutase signature 2.	SODC_HUMAN	139-150	2	A:97-106 B:97-106

Biological Unit 1 (2, 2)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	SOD_CU_ZN_1	PS00087	Copper/Zinc superoxide dismutase signature 1.	SODC_HUMAN	45-55	1	A:44-51 -
2	SOD_CU_ZN_2	PS00332	Copper/Zinc superoxide dismutase signature 2.	SODC_HUMAN	139-150	1	A:97-106 -

Biological Unit 2 (2, 2)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	SOD_CU_ZN_1	PS00087	Copper/Zinc superoxide dismutase signature 1.	SODC_HUMAN	45-55	1	- B:44-51
2	SOD_CU_ZN_2	PS00332	Copper/Zinc superoxide dismutase signature 2.	SODC_HUMAN	139-150	1	- B:97-106

Asymmetric Unit (4, 8)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1a	ENST00000270142	1a	ENSE00001507447	chr21:33031935-33032154	220	SODC_HUMAN	1-24	24	2	A:1-23 B:2-23	23 22
1.3	ENST00000270142	3	ENSE00001507446	chr21:33036103-33036199	97	SODC_HUMAN	25-57	33	2	A:24-51 B:24-51	28 28
1.4	ENST00000270142	4	ENSE00000952640	chr21:33038762-33038831	70	SODC_HUMAN	57-80	24	0	-	-
1.5b	ENST00000270142	5b	ENSE00000952641	chr21:33039571-33039688	118	SODC_HUMAN	80-119	40	2	A:52-88 B:52-88	37 37
1.6	ENST00000270142	6	ENSE00001847240	chr21:33040784-33041244	461	SODC_HUMAN	120-154	35	2	A:89-110 (gaps) B:89-110 (gaps)	35 35

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:110
 aligned with SODC_HUMAN | P00441 from UniProtKB/Swiss-Prot  Length:154

    Alignment length:153
                                    11        21        31        41        51        61        71        81        91       101       111       121       131       141       151   
           SODC_HUMAN     2 ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ 154
               SCOP domains --------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..eeeeeee.....eeeeeee.......eeeeeeee....eeeeeee....------------------------------.eeeeeee.....eeeeeee..............eeeee...---...----------....eeeeeeeeee Sec.struct. author
             SAPs(SNPs) (1) ---S-FEQ---R-G-S---CGL--------------RR--D-R-CR-QK----------------------------------FRSA-TA--A-G-M--GG--FLV-V--YMTAG--L-------------------------FTRRGT-T-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ---T---V-----M------K----------------V--S------R-----------------------------------V----VV--C------KN----------T-------------------------------S---I----- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ---V----------------------------------------------------------------------------------------D------------------------------------------------------------ SAPs(SNPs) (3)
             SAPs(SNPs) (4) --------------------------------------------------------------------------------------------R------------------------------------------------------------ SAPs(SNPs) (4)
             SAPs(SNPs) (5) --------------------------------------------------------------------------------------------V------------------------------------------------------------ SAPs(SNPs) (5)
                    PROSITE -------------------------------------------SOD_CU_ZN_1-----------------------------------------------------------------------------------SOD_CU_ZN_2 ---- PROSITE
           Transcript 1 (1) Exon 1.1a  PDB: A:1-23 Exon 1.3  PDB: A:24-51           ----------------------Exon 1.5b  PDB: A:52-88 UniProt: 80-119 Exon 1.6  PDB: A:89-110 (gaps)      Transcript 1 (1)
           Transcript 1 (2) -------------------------------------------------------Exon 1.4  PDB: -        -------------------------------------------------------------------------- Transcript 1 (2)
                 4bcz A   1 ATKAVAVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHGAG------------------------------GDLGNVTADKDGVADVSIEDSVISLSGDHSIIGRTLVVHEKA---GAG----------AGSRLASGVIGIAQ 110
                                    10        20        30        40        50|        -         -         - |      60        70        80        90  |   | |-        97       107   
                                                                             51                             52                                       93  94 |         97             
                                                                                                                                                           96

Chain B from PDB  Type:PROTEIN  Length:109
 aligned with SODC_HUMAN | P00441 from UniProtKB/Swiss-Prot  Length:154

    Alignment length:152
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152  
           SODC_HUMAN     3 TKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ 154
               SCOP domains -------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains -------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .eeeeeee.....eeeeeeee......eeeeeeee....eeeeeee....------------------------------.eeeeeee.....eeeeeee..............eeeee...---...----------....eeeeeeeee. Sec.struct. author
             SAPs(SNPs) (1) --S-FEQ---R-G-S---CGL--------------RR--D-R-CR-QK----------------------------------FRSA-TA--A-G-M--GG--FLV-V--YMTAG--L-------------------------FTRRGT-T-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --T---V-----M------K----------------V--S------R-----------------------------------V----VV--C------KN----------T-------------------------------S---I----- SAPs(SNPs) (2)
             SAPs(SNPs) (3) --V----------------------------------------------------------------------------------------D------------------------------------------------------------ SAPs(SNPs) (3)
             SAPs(SNPs) (4) -------------------------------------------------------------------------------------------R------------------------------------------------------------ SAPs(SNPs) (4)
             SAPs(SNPs) (5) -------------------------------------------------------------------------------------------V------------------------------------------------------------ SAPs(SNPs) (5)
                    PROSITE ------------------------------------------SOD_CU_ZN_1-----------------------------------------------------------------------------------SOD_CU_ZN_2 ---- PROSITE
           Transcript 1 (1) Exon 1.1a  PDB: B:2-23Exon 1.3  PDB: B:24-51           ----------------------Exon 1.5b  PDB: B:52-88 UniProt: 80-119 Exon 1.6  PDB: B:89-110 (gaps)      Transcript 1 (1)
           Transcript 1 (2) ------------------------------------------------------Exon 1.4  PDB: -        -------------------------------------------------------------------------- Transcript 1 (2)
                 4bcz B   2 TKAVAVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHGAG------------------------------GDLGNVTADKDGVADVSIEDSVISLSGDHSIIGRTLVVHEKA---GAG----------AGSRLASGVIGIAQ 110
                                    11        21        31        41        51         -         -         -|       61        71        81        91 |   | | -        98       108  
                                                                            51                             52                                       93  94 |         97             
                                                                                                                                                          96

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

(no "SCOP Domain" information available for 4BCZ)

(no "CATH Domain" information available for 4BCZ)

(no "Pfam Domain" information available for 4BCZ)

Asymmetric Unit(hide GO term definitions)

Chain A,B (SODC_HUMAN | P00441)

molecular function
	GO:0048365	Rac GTPase binding	Interacting selectively and non-covalently with Rac protein, any member of the Rac subfamily of the Ras superfamily of monomeric GTPases.
	GO:0016209	antioxidant activity	Inhibition of the reactions brought about by dioxygen (O2) or peroxides. Usually the antioxidant is effective because it can itself be more easily oxidized than the substance protected. The term is often applied to components that can trap free radicals, thereby breaking the chain reaction that normally leads to extensive biological damage.
	GO:0051087	chaperone binding	Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.
	GO:0005507	copper ion binding	Interacting selectively and non-covalently with copper (Cu) ions.
	GO:0019899	enzyme binding	Interacting selectively and non-covalently with any enzyme.
	GO:0042802	identical protein binding	Interacting selectively and non-covalently with an identical protein or proteins.
	GO:0046872	metal ion binding	Interacting selectively and non-covalently with any metal ion.
	GO:0016491	oxidoreductase activity	Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0042803	protein homodimerization activity	Interacting selectively and non-covalently with an identical protein to form a homodimer.
	GO:0030346	protein phosphatase 2B binding	Interacting selectively and non-covalently with the enzyme protein phosphatase 2B.
	GO:0004784	superoxide dismutase activity	Catalysis of the reaction: 2 superoxide + 2 H+ = O2 + hydrogen peroxide.
	GO:0008270	zinc ion binding	Interacting selectively and non-covalently with zinc (Zn) ions.
biological process
	GO:0000187	activation of MAPK activity	The initiation of the activity of the inactive enzyme MAP kinase (MAPK).
	GO:0007568	aging	A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
	GO:0008089	anterograde axonal transport	The directed movement of organelles or molecules along microtubules from the cell body toward the cell periphery in nerve cell axons.
	GO:0060088	auditory receptor cell stereocilium organization	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a stereocilium. A stereocilium is an actin-based protrusion from the apical surface of auditory hair cells.
	GO:0007569	cell aging	An aging process that has as participant a cell after a cell has stopped dividing. Cell aging may occur when a cell has temporarily stopped dividing through cell cycle arrest (GO:0007050) or when a cell has permanently stopped dividing, in which case it is undergoing cellular senescence (GO:0090398). May precede cell death (GO:0008219) and succeed cell maturation (GO:0048469).
	GO:0006879	cellular iron ion homeostasis	Any process involved in the maintenance of an internal steady state of iron ions at the level of a cell.
	GO:0071318	cellular response to ATP	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ATP (adenosine 5'-triphosphate) stimulus.
	GO:0071276	cellular response to cadmium ion	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus.
	GO:0034599	cellular response to oxidative stress	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
	GO:0035865	cellular response to potassium ion	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a potassium ion stimulus.
	GO:0007566	embryo implantation	Attachment of the blastocyst to the uterine lining.
	GO:0006749	glutathione metabolic process	The chemical reactions and pathways involving glutathione, the tripeptide glutamylcysteinylglycine, which acts as a coenzyme for some enzymes and as an antioxidant in the protection of sulfhydryl groups in enzymes and other proteins; it has a specific role in the reduction of hydrogen peroxide (H2O2) and oxidized ascorbate, and it participates in the gamma-glutamyl cycle.
	GO:0060047	heart contraction	The multicellular organismal process in which the heart decreases in volume in a characteristic way to propel blood through the body.
	GO:0050665	hydrogen peroxide biosynthetic process	The chemical reactions and pathways resulting in the formation of hydrogen peroxide (H2O2), a potentially harmful byproduct of aerobic cellular respiration which can cause damage to DNA.
	GO:0007626	locomotory behavior	The specific movement from place to place of an organism in response to external or internal stimuli. Locomotion of a whole organism in a manner dependent upon some combination of that organism's internal state and external conditions.
	GO:0046716	muscle cell cellular homeostasis	The cellular homeostatic process that preserves a muscle cell in a stable functional or structural state.
	GO:0002262	myeloid cell homeostasis	The process of regulating the proliferation and elimination of myeloid cells such that the total number of myeloid cells within a whole or part of an organism is stable over time in the absence of an outside stimulus.
	GO:0043066	negative regulation of apoptotic process	Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
	GO:0045541	negative regulation of cholesterol biosynthetic process	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cholesterol.
	GO:0043524	negative regulation of neuron apoptotic process	Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
	GO:0060052	neurofilament cytoskeleton organization	A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising neurofilaments and their associated proteins.
	GO:0001541	ovarian follicle development	The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
	GO:0055114	oxidation-reduction process	A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.
	GO:0032287	peripheral nervous system myelin maintenance	The process in which the structure and material content of mature peripheral nervous system myelin is kept in a functional state.
	GO:0001890	placenta development	The process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin.
	GO:0002576	platelet degranulation	The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
	GO:0043065	positive regulation of apoptotic process	Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
	GO:0043085	positive regulation of catalytic activity	Any process that activates or increases the activity of an enzyme.
	GO:0001819	positive regulation of cytokine production	Any process that activates or increases the frequency, rate or extent of production of a cytokine.
	GO:1902177	positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	Any process that activates or increases the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway.
	GO:0032930	positive regulation of superoxide anion generation	Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell.
	GO:0072593	reactive oxygen species metabolic process	The chemical reactions and pathways involving a reactive oxygen species, any molecules or ions formed by the incomplete one-electron reduction of oxygen. They contribute to the microbicidal activity of phagocytes, regulation of signal transduction and gene expression, and the oxidative damage to biopolymers.
	GO:0043087	regulation of GTPase activity	Any process that modulates the rate of GTP hydrolysis by a GTPase.
	GO:0033081	regulation of T cell differentiation in thymus	Any process that modulates the frequency, rate or extent of T cell differentiation in the thymus.
	GO:0008217	regulation of blood pressure	Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
	GO:0051881	regulation of mitochondrial membrane potential	Any process that modulates the establishment or extent of the mitochondrial membrane potential, the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
	GO:0040014	regulation of multicellular organism growth	Any process that modulates the frequency, rate or extent of growth of the body of an organism so that it reaches its usual body size.
	GO:0046620	regulation of organ growth	Any process that modulates the frequency, rate or extent of growth of an organ of an organism.
	GO:0045859	regulation of protein kinase activity	Any process that modulates the frequency, rate or extent of protein kinase activity.
	GO:0060087	relaxation of vascular smooth muscle	A negative regulation of smooth muscle contraction resulting in relaxation of vascular smooth muscle. The relaxation is mediated by a decrease in the phosphorylation state of myosin light chain. This can be achieved by removal of calcium from the cytoplasm to the sarcoplasmic reticulum lumen through the action of Ca2+ ATPases leading to a decrease myosin light chain kinase activity, and through calcium-independent pathways leading to a increase in myosin light chain phosphatase activity.
	GO:0019430	removal of superoxide radicals	Any process, acting at the cellular level, involved in removing superoxide radicals (O2-) from a cell or organism, e.g. by conversion to dioxygen (O2) and hydrogen peroxide (H2O2).
	GO:0001975	response to amphetamine	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amphetamine stimulus. Amphetamines consist of a group of compounds related to alpha-methylphenethylamine.
	GO:0046677	response to antibiotic	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms.
	GO:0097332	response to antipsychotic drug	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antipsychotic drug stimulus. Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.
	GO:0048678	response to axon injury	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an axon injury stimulus.
	GO:0034465	response to carbon monoxide	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carbon monoxide (CO) stimulus.
	GO:0046688	response to copper ion	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus.
	GO:0042493	response to drug	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
	GO:0045471	response to ethanol	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.
	GO:0009408	response to heat	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism.
	GO:0042542	response to hydrogen peroxide	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
	GO:0031667	response to nutrient levels	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients.
	GO:0010033	response to organic substance	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
	GO:0006979	response to oxidative stress	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
	GO:0000302	response to reactive oxygen species	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.
	GO:0000303	response to superoxide	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a superoxide stimulus. Superoxide is the anion, oxygen-, formed by addition of one electron to dioxygen (O2) or any compound containing the superoxide anion.
	GO:0001895	retina homeostasis	A tissue homeostatic process involved in the maintenance of an internal equilibrium within the retina of the eye, including control of cellular proliferation and death and control of metabolic function.
	GO:0008090	retrograde axonal transport	The directed movement of organelles or molecules along microtubules from the cell periphery toward the cell body in nerve cell axons.
	GO:0007605	sensory perception of sound	The series of events required for an organism to receive an auditory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Sonic stimuli are detected in the form of vibrations and are processed to form a sound.
	GO:0007283	spermatogenesis	The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
	GO:0042554	superoxide anion generation	The enzymatic generation of superoxide, the superoxide anion O2- (superoxide free radical), or any compound containing this species, by a cell in response to environmental stress, thereby mediating the activation of various stress-inducible signaling pathways.
	GO:0006801	superoxide metabolic process	The chemical reactions and pathways involving superoxide, the superoxide anion O2- (superoxide free radical), or any compound containing this species.
	GO:0048538	thymus development	The process whose specific outcome is the progression of the thymus over time, from its formation to the mature structure. The thymus is a symmetric bi-lobed organ involved primarily in the differentiation of immature to mature T cells, with unique vascular, nervous, epithelial, and lymphoid cell components.
	GO:0019226	transmission of nerve impulse	The neurological system process in which a signal is transmitted through the nervous system by a combination of action potential propagation and synaptic transmission.
cellular component
	GO:1904115	axon cytoplasm	Any cytoplasm that is part of a axon.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0031410	cytoplasmic vesicle	A vesicle found in the cytoplasm of a cell.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0032839	dendrite cytoplasm	All of the contents of a dendrite, excluding the surrounding plasma membrane.
	GO:0031045	dense core granule	Electron-dense organelle with a granular internal matrix; contains proteins destined to be secreted.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0031012	extracellular matrix	A structure lying external to one or more cells, which provides structural support for cells or tissues.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0005764	lysosome	A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
	GO:0005758	mitochondrial intermembrane space	The region between the inner and outer lipid bilayers of the mitochondrial envelope.
	GO:0005759	mitochondrial matrix	The gel-like material, with considerable fine structure, that lies in the matrix space, or lumen, of a mitochondrion. It contains the enzymes of the tricarboxylic acid cycle and, in some organisms, the enzymes concerned with fatty acid oxidation.
	GO:0005739	mitochondrion	A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
	GO:0043209	myelin sheath	An electrically insulating fatty layer that surrounds the axons of many neurons. It is an outgrowth of glial cells: Schwann cells supply the myelin for peripheral neurons while oligodendrocytes supply it to those of the central nervous system.
	GO:0043005	neuron projection	A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
	GO:0043025	neuronal cell body	The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
	GO:0005654	nucleoplasm	That part of the nuclear content other than the chromosomes or the nucleolus.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
	GO:0005777	peroxisome	A small organelle enclosed by a single membrane, and found in most eukaryotic cells. Contains peroxidases and other enzymes involved in a variety of metabolic processes including free radical detoxification, lipid catabolism and biosynthesis, and hydrogen peroxide metabolism.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
	GO:0043234	protein complex	A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical.
	GO:0030141	secretory granule	A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
(no "Ligands, Modified Residues, Ions" information available for 4bcz)

	Sites
(no "Sites" information available for 4bcz)

	Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 4bcz)

Biological Units
	Complete Structure
		Biological Unit 1	[ Jena3D ]
		Biological Unit 2	[ Jena3D ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym. Unit PNG format \| Biol. Unit 1 PNG format \| Biol. Unit 2 PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	4bcz
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	SODC_HUMAN \| P00441
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	1.15.1.1
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	105400
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	SODC_HUMAN \| P00441
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

1azv	FAMILIAL ALS MUTANT G37R CUZNSOD (HUMAN)
1ba9	THE SOLUTION STRUCTURE OF REDUCED MONOMERIC SUPEROXIDE DISMUTASE, NMR, 36 STRUCTURES
1dsw	THE SOLUTION STRUCTURE OF A MONOMERIC, REDUCED FORM OFHUMAN COPPER, ZINC SUPEROXIDE DISMUTASE BEARING THE SAMECHARGE AS THE NATIVE PROTEIN
1fun	SUPEROXIDE DISMUTASE MUTANT WITH LYS 136 REPLACED BY GLU, CYS 6 REPLACED BY ALA AND CYS 111 REPLACED BY SER (K136E, C6A, C111S)
1hl4	THE STRUCTURE OF APO TYPE HUMAN CU, ZN SUPEROXIDE DISMUTASE
1hl5	THE STRUCTURE OF HOLO TYPE HUMAN CU, ZN SUPEROXIDE DISMUTASE
1kmg	THE SOLUTION STRUCTURE OF MONOMERIC COPPER-FREE SUPEROXIDEDISMUTASE
1l3n	THE SOLUTION STRUCTURE OF REDUCED DIMERIC COPPER ZINC SOD:THE STRUCTURAL EFFECTS OF DIMERIZATION
1mfm	MONOMERIC HUMAN SOD MUTANT F50E/G51E/E133Q AT ATOMIC RESOLUTION
1n18	THERMOSTABLE MUTANT OF HUMAN SUPEROXIDE DISMUTASE, C6A, C111S
1n19	STRUCTURE OF THE HSOD A4V MUTANT
1oez	ZN HIS46ARG MUTANT OF HUMAN CU, ZN SUPEROXIDE DISMUTASE
1ozt	CRYSTAL STRUCTURE OF APO-H46R FAMILIAL ALS MUTANT HUMAN CU,ZN SUPEROXIDE DISMUTASE (CUZNSOD) TO 2.5A RESOLUTION
1ozu	CRYSTAL STRUCTURE OF FAMILIAL ALS MUTANT S134N OF HUMAN CU,ZN SUPEROXIDE DISMUTASE (CUZNSOD) TO 1.3A RESOLUTION
1p1v	CRYSTAL STRUCTURE OF FALS-ASSOCIATED HUMAN COPPER- ZINCSUPEROXIDE DISMUTASE (CUZNSOD) MUTANT D125H TO 1.4A
1ptz	CRYSTAL STRUCTURE OF THE HUMAN CU, ZN SUPEROXIDE DISMUTASE,FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS (FALS) MUTANT H43R
1pu0	STRUCTURE OF HUMAN CU,ZN SUPEROXIDE DISMUTASE
1rk7	SOLUTION STRUCTURE OF APO CU,ZN SUPEROXIDE DISMUTASE: ROLEOF METAL IONS IN PROTEIN FOLDING
1sos	SUPEROXIDE DISMUTASE MUTANT WITH CYS 6 REPLACED BY ALA AND CYS 111 REPLACED BY SER (C6A, C111S)
1spd	SUPEROXIDE DISMUTASE
1uxl	I113T MUTANT OF HUMAN SOD1
1uxm	A4V MUTANT OF HUMAN SOD1
2af2	SOLUTION STRUCTURE OF DISULFIDE REDUCED AND COPPER DEPLETEDHUMAN SUPEROXIDE DISMUTASE
2c9s	1.24 ANGSTROMS RESOLUTION STRUCTURE OF ZN-ZN HUMAN SUPEROXIDE DISMUTASE
2c9u	1.24 ANGSTROMS RESOLUTION STRUCTURE OF AS-ISOLATED CU -ZN HUMAN SUPEROXIDE DISMUTASE
2c9v	ATOMIC RESOLUTION STRUCTURE OF CU-ZN HUMAN SUPEROXIDE DISMUTASE
2v0a	ATOMIC RESOLUTION CRYSTAL STRUCTURE OF HUMAN SUPEROXIDE DISMUTASE
2vr6	CRYSTAL STRUCTURE OF G85R ALS MUTANT OF HUMAN CU,ZN SUPEROXIDE DISMUTASE (CUZNSOD) AT 1.3 A RESOLUTION
2vr7	CRYSTAL STRUCTURE OF G85R ALS MUTANT OF HUMAN CU,ZN SUPEROXIDE DISMUTASE (CUZNSOD) AT 1.58 A RESOLUTION
2vr8	CRYSTAL STRUCTURE OF G85R ALS MUTANT OF HUMAN CU,ZN SUPEROXIDE DISMUTASE (CUZNSOD) AT 1.36 A RESOLUTION
2wko	STRUCTURE OF METAL LOADED PATHOGENIC SOD1 MUTANT G93A.
2wyt	1.0 A RESOLUTION STRUCTURE OF L38V SOD1 MUTANT
2wyz	L38V SOD1 MUTANT COMPLEXED WITH UMP
2wz0	L38V SOD1 MUTANT COMPLEXED WITH ANILINE.
2wz5	L38V SOD1 MUTANT COMPLEXED WITH L-METHIONINE.
2wz6	G93A SOD1 MUTANT COMPLEXED WITH QUINAZOLINE.
2xjk	MONOMERIC HUMAN CU,ZN SUPEROXIDE DISMUTASE
2xjl	MONOMERIC HUMAN CU,ZN SUPEROXIDE DISMUTASE WITHOUT CU LIGANDS
4a7g	STRUCTURE OF HUMAN I113T SOD1 MUTANT COMPLEXED WITH 4 -METHYLPIPERAZIN-1-YL)QUINAZOLINE IN THE P21 SPACE GROUP.
4a7q	STRUCTURE OF HUMAN I113T SOD1 MUTANT COMPLEXED WITH 4 -(4-METHYL-1,4-DIAZEPAN-1-YL)QUINAZOLINE IN THE P21 SPACE GROUP.
4a7r	STRUCTURE OF HUMAN I113T SOD1 MUTANT COMPLEXED WITH 4 -(4-METHYL-1,4-DIAZEPAN-1-YL)-2-(TRIFLUOROMETHYL) QUINAZOLINE IN THE P21 SPACE GROUP
4a7s	STRUCTURE OF HUMAN I113T SOD1 MUTANT COMPLEXED WITH 5 -FLUOROURIDINE IN THE P21 SPACE GROUP
4a7t	STRUCTURE OF HUMAN I113T SOD1 MUTANT COMPLEXED WITH ISOPROTERANOL IN THE P21 SPACE GROUP
4a7u	STRUCTURE OF HUMAN I113T SOD1 COMPLEXED WITH ADRENALINE IN THE P21 SPACE GROUP.
4a7v	STRUCTURE OF HUMAN I113T SOD1 MUTANT COMPLEXED WITH DOPAMINE IN THE P21 SPACE GROUP
4b3e	STRUCTURE OF COPPER-ZINC SUPEROXIDE DISMUTASE COMPLEXED WITH BICARBONATE.
4bcy	MONOMERIC HUMAN CU,ZN SUPEROXIDE DISMUTASE, MUTATION H43F

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (0, 0)

Sites (0, 0)

SS Bonds (0, 0)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (66, 132)

PROSITE Motifs (2, 4)

Exons (4, 8)

Sequences/Alignments

Classification and Annotation

SCOP Domains (0, 0)

CATH Domains (0, 0)

Pfam Domains (0, 0)

Gene Ontology (100, 100)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File